Literature DB >> 35438161

Inhibition of infection-induced vascular permeability modulates host leukocyte recruitment to Mycobacterium marinum granulomas in zebrafish.

Julia Y Kam1, Tina Cheng1, Danielle C Garland1, Warwick J Britton1,2, David M Tobin3, Stefan H Oehlers1,4,5.   

Abstract

Mycobacterial granuloma formation involves significant stromal remodeling including the growth of leaky, granuloma-associated vasculature. These permeable blood vessels aid mycobacterial growth, as antiangiogenic or vascular normalizing therapies are beneficial host-directed therapies in preclinical models of tuberculosis across host-mycobacterial pairings. Using the zebrafish-Mycobacterium marinum infection model, we demonstrate that vascular normalization by inhibition of vascular endothelial protein tyrosine phosphatase (VE-PTP) decreases granuloma hypoxia, the opposite effect of hypoxia-inducing antiangiogenic therapy. Inhibition of VE-PTP decreased neutrophil recruitment to granulomas in adult and larval zebrafish, and decreased the proportion of neutrophils that extravasated distal to granulomas. Furthermore, VE-PTP inhibition increased the accumulation of T cells at M. marinum granulomas. Our study provides evidence that, similar to the effect in solid tumors, vascular normalization during mycobacterial infection increases the T cell:neutrophil ratio in lesions which may be correlates of protective immunity.
© The Author(s) 2022. Published by Oxford University Press on behalf of FEMS.

Entities:  

Keywords:  T cell; mycobacteria; neutrophil; vascular permeability; zebrafish

Mesh:

Year:  2022        PMID: 35438161      PMCID: PMC9053305          DOI: 10.1093/femspd/ftac009

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.951


  34 in total

1.  Mycobacterium marinum infection of adult zebrafish causes caseating granulomatous tuberculosis and is moderated by adaptive immunity.

Authors:  Laura E Swaim; Lynn E Connolly; Hannah E Volkman; Olivier Humbert; Donald E Born; Lalita Ramakrishnan
Journal:  Infect Immun       Date:  2006-11       Impact factor: 3.441

2.  Activation of hypoxia-inducible factor-1α (Hif-1α) delays inflammation resolution by reducing neutrophil apoptosis and reverse migration in a zebrafish inflammation model.

Authors:  Philip M Elks; Fredericus J van Eeden; Giles Dixon; Xingang Wang; Constantino Carlos Reyes-Aldasoro; Philip W Ingham; Moira K B Whyte; Sarah R Walmsley; Stephen A Renshaw
Journal:  Blood       Date:  2011-05-09       Impact factor: 22.113

3.  Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy.

Authors:  Yuhui Huang; Jianping Yuan; Elda Righi; Walid S Kamoun; Marek Ancukiewicz; Jean Nezivar; Michael Santosuosso; John D Martin; Margaret R Martin; Fabrizio Vianello; Pierre Leblanc; Lance L Munn; Peigen Huang; Dan G Duda; Dai Fukumura; Rakesh K Jain; Mark C Poznansky
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-08       Impact factor: 11.205

4.  Evaluation of the pathogenesis and treatment of Mycobacterium marinum infection in zebrafish.

Authors:  Kevin Takaki; J Muse Davis; Kathryn Winglee; Lalita Ramakrishnan
Journal:  Nat Protoc       Date:  2013-05-16       Impact factor: 13.491

5.  Effects of vascular-endothelial protein tyrosine phosphatase inhibition on breast cancer vasculature and metastatic progression.

Authors:  Shom Goel; Nisha Gupta; Brian P Walcott; Matija Snuderl; Cristina T Kesler; Nathaniel D Kirkpatrick; Takahiro Heishi; Yuhui Huang; John D Martin; Eleanor Ager; Rekha Samuel; Shuhan Wang; John Yazbek; Benjamin J Vakoc; Randall T Peterson; Timothy P Padera; Dan G Duda; Dai Fukumura; Rakesh K Jain
Journal:  J Natl Cancer Inst       Date:  2013-07-30       Impact factor: 13.506

Review 6.  Neutrophils in tuberculosis: friend or foe?

Authors:  David M Lowe; Paul S Redford; Robert J Wilkinson; Anne O'Garra; Adrian R Martineau
Journal:  Trends Immunol       Date:  2011-11-15       Impact factor: 16.687

7.  Interception of host angiogenic signalling limits mycobacterial growth.

Authors:  Stefan H Oehlers; Mark R Cronan; Ninecia R Scott; Monica I Thomas; Kazuhide S Okuda; Eric M Walton; Rebecca W Beerman; Philip S Crosier; David M Tobin
Journal:  Nature       Date:  2014-11-24       Impact factor: 49.962

8.  Angiopoietin-2-induced blood-brain barrier compromise and increased stroke size are rescued by VE-PTP-dependent restoration of Tie2 signaling.

Authors:  Stefanie Gurnik; Kavi Devraj; Jadranka Macas; Maiko Yamaji; Julia Starke; Alexander Scholz; Kathleen Sommer; Mariangela Di Tacchio; Rajkumar Vutukuri; Heike Beck; Michel Mittelbronn; Christian Foerch; Waltraud Pfeilschifter; Stefan Liebner; Kevin G Peters; Karl H Plate; Yvonne Reiss
Journal:  Acta Neuropathol       Date:  2016-03-01       Impact factor: 17.088

9.  Matrix metalloproteinase inhibitors enhance the efficacy of frontline drugs against Mycobacterium tuberculosis.

Authors:  Yitian Xu; Lihua Wang; Matthew D Zimmerman; Kai-Yuan Chen; Lu Huang; Dah-Jiun Fu; Firat Kaya; Nikolai Rakhilin; Evgeniya V Nazarova; Pengcheng Bu; Veronique Dartois; David G Russell; Xiling Shen
Journal:  PLoS Pathog       Date:  2018-04-26       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.